Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 4
2006 1
2007 1
2008 1
2013 2
2014 5
2015 1
2017 2
2018 1
2019 5
2020 5
2021 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Simultaneous treatment with sorafenib and glucose restriction inhibits hepatocellular carcinoma in vitro and in vivo by impairing SIAH1-mediated mitophagy.
Zhou J, Feng J, Wu Y, Dai HQ, Zhu GZ, Chen PH, Wang LM, Lu G, Liao XW, Lu PZ, Su WJ, Hooi SC, Ye XP, Shen HM, Peng T, Lu GD. Zhou J, et al. Among authors: lu pz. Exp Mol Med. 2022 Nov;54(11):2007-2021. doi: 10.1038/s12276-022-00878-x. Epub 2022 Nov 16. Exp Mol Med. 2022. PMID: 36385558 Free PMC article.
ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma.
Feng J, Lu PZ, Zhu GZ, Hooi SC, Wu Y, Huang XW, Dai HQ, Chen PH, Li ZJ, Su WJ, Han CY, Ye XP, Peng T, Zhou J, Lu GD. Feng J, et al. Among authors: lu pz. Acta Pharmacol Sin. 2021 Jan;42(1):160-170. doi: 10.1038/s41401-020-0439-x. Epub 2020 Jun 15. Acta Pharmacol Sin. 2021. PMID: 32541921 Free PMC article.
25 results